This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novozymes A/s. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Johanne Mørch Jensen: Innovator in Alpha-Amylase Variants
Introduction
Johanne Mørch Jensen is a prominent inventor based in Holte, Denmark. She has made significant contributions to the field of biotechnology, particularly in the development of alpha-amylase variants. Her work has implications for various industrial applications, showcasing her innovative spirit and dedication to scientific advancement.
Latest Patents
Johanne Mørch Jensen holds a patent for "Alpha-amylase variants and polynucleotides encoding same." This invention relates to alpha-amylase variants that include specific substitutions at positions corresponding to positions 268 and 293 of SEQ ID NO: 1. The variants exhibit a high degree of sequence identity to parent alpha-amylases, making them valuable for various applications. The patent emphasizes the importance of these variants in enhancing enzymatic processes.
Career Highlights
Johanne Mørch Jensen is associated with Novozymes A/S, a leading company in the field of biotechnology. Her role at Novozymes has allowed her to work on cutting-edge research and development projects. With her expertise, she has contributed to the advancement of enzyme technology, which is crucial for numerous industries.
Collaborations
Johanne has collaborated with notable colleagues, including Carsten Schau Andersen and Lars Giger. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Johanne Mørch Jensen is a trailblazer in the field of alpha-amylase variants, with a patent that highlights her innovative contributions. Her work at Novozymes A/S and collaborations with esteemed colleagues further underscore her impact on biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
